Jefferies Financial Group restated their buy rating on shares of Entain (LON:ENT – Free Report) in a research report report published on Monday morning, Marketbeat.com reports. Jefferies Financial Group currently has a GBX 1,140 ($14.33) price objective on the stock.
Several other research firms have also recently commented on ENT. JPMorgan Chase & Co. restated a “neutral” rating on shares of Entain in a research note on Wednesday, September 11th. Berenberg Bank cut their target price on Entain from GBX 1,030 ($12.95) to GBX 1,010 ($12.70) and set a “neutral” rating for the company in a research note on Thursday, November 7th. Finally, Shore Capital restated a “buy” rating on shares of Entain in a research note on Monday, September 9th. Three research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, Entain currently has an average rating of “Moderate Buy” and an average target price of GBX 1,077.25 ($13.54).
Get Our Latest Stock Analysis on Entain
Entain Stock Down 2.7 %
Insider Transactions at Entain
In other news, insider Ricky Sandler sold 4,334,882 shares of Entain stock in a transaction on Monday, December 2nd. The stock was sold at an average price of GBX 806 ($10.13), for a total transaction of £34,939,148.92 ($43,926,513.60). Corporate insiders own 0.26% of the company’s stock.
Entain Company Profile
Entain Plc operates as a sports-betting and gaming company. The company provides online and multi-channel betting under the Ladbrokes name; street and online betting under the Coral name; online sports betting, casino, and gaming under the Eurobet name; scores, sports information, editorial and social content, and sports focused free-to play games under the 365Scores name; sports betting and games under the SuperSport and BetCity names; online betting under the bwin name; and sports betting, poker, and casino games under the Crystalbet name.
Featured Stories
- Five stocks we like better than Entain
- Investing in Commodities: What Are They? How to Invest in Them
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- ETF Screener: Uses and Step-by-Step Guide
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Entain Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Entain and related companies with MarketBeat.com's FREE daily email newsletter.